Comprehensive Introduction to the AXIOS Lumen-Apposing Metal Stent (LAMS)

The evolution of minimally invasive interventional endoscopy has been fundamentally transformed by the introduction of the Lumen-Apposing Metal Stent (LAMS). Specifically, the AXIOS Stent and Delivery System has emerged as the gold standard for internal drainage of peripancreatic fluid collections (PFCs) and symptomatic gallbladder disease in patients who are poor surgical candidates.

Unlike traditional plastic stents or self-expanding metal stents (SEMS) designed for biliary or esophageal use, the LAMS is engineered with a unique “dumbbell” or “bi-flanged” geometry. This design is specifically intended to pull two disparate tissue layers together, creating a secure, apposed fistula. As an orthopedic and interventional specialist, understanding the biomechanical integrity and material science behind these devices is crucial for optimizing patient outcomes in complex interventional procedures.

Technical Specifications and Mechanism of Action

The AXIOS LAMS is composed of a laser-cut Nitinol (Nickel-Titanium alloy) structure, chosen for its exceptional shape-memory properties and biocompatibility. The stent is fully covered by a silicone layer to prevent tissue ingrowth, which is essential for eventual removal after the clinical objective has been achieved.

Key Design Features

The Biomechanics of Apposition

The core mechanism of the AXIOS stent relies on the radial force exerted by the flanges. Once deployed, the proximal and distal flanges expand to a diameter larger than the central lumen. This creates a "clamping" force that pulls the organ wall (e.g., the stomach wall) against the target collection (e.g., the pancreatic pseudocyst). This tissue apposition minimizes the risk of leakage into the peritoneal cavity, which is the primary concern during transmural drainage.

Clinical Indications and Usage

The AXIOS LAMS is primarily indicated for the drainage of symptomatic peripancreatic fluid collections. The choice of diameter (10mm, 15mm, or 20mm) is determined by the nature of the collection, the viscosity of the contents, and the clinical goals of the procedure.

1. Pancreatic Pseudocysts and Walled-Off Necrosis (WON)

The 15mm and 20mm stents are frequently employed for Walled-Off Necrosis (WON). The larger diameter is critical here to allow for the passage of necrosectomy instruments (such as snares or baskets) and to permit the spontaneous evacuation of solid necrotic debris.

2. Symptomatic Gallbladder Disease

For patients with acute cholecystitis who are deemed high-risk for surgery, the 10mm AXIOS stent is used for Endoscopic Ultrasound-guided Gallbladder Drainage (EUS-GBD). This creates a cholecystogastric or cholecystoduodenal fistula, relieving the obstruction and infection without the need for invasive cholecystectomy.

3. Usage Protocols

• Access: EUS-guided puncture is performed using the electrocautery-enhanced delivery system.
• Deployment: The distal flange is deployed within the target cavity under endoscopic and fluoroscopic visualization.
• Apposition: The stent is retracted slightly to ensure the distal flange is flush against the wall, then the proximal flange is deployed within the stomach or duodenum.
• Verification: Confirm patency via endoscopic visualization of the lumen.

Maintenance, Sterilization, and Handling

The AXIOS LAMS is a single-use, sterile device. In an orthopedic or surgical environment, adherence to strict sterility protocols is non-negotiable.

• Handling: Do not remove the stent from the delivery system until immediately before use. Avoid bending the catheter at sharp angles, as this can compromise the Nitinol structure.
• Sterilization: The device is provided sterile (Ethylene Oxide). It is not intended for re-sterilization. Attempting to re-sterilize the device can lead to degradation of the silicone coating and loss of radial force.
• Storage: Store in a cool, dry place. Exposure to extreme temperatures can affect the shape-memory characteristics of the Nitinol alloy.

Risks, Side Effects, and Contraindications

While the AXIOS LAMS is highly effective, it is not without risk. Clinicians must perform a rigorous pre-procedural assessment to mitigate these complications.

Potential Adverse Events

• Stent Migration: Although the flanges are designed to prevent this, improper sizing or excessive movement can lead to internal or external migration.
• Bleeding: Often occurring at the site of the fistula creation. Proper EUS assessment of intervening vessels (using Color Doppler) is mandatory.
• Perforation: If the distance between the two organs is insufficient, the stent may not adequately seal the fistula, leading to peritonitis.
• Infection: Incomplete drainage or obstruction of the stent can lead to superimposed infection.

Contraindications

• Uncorrectable coagulopathy.
• Inability to safely access the target organ via EUS due to anatomical interposition of blood vessels or other organs.
• Known allergy to Nickel (due to the Nitinol construction).

Patient Outcome Improvements

The transition from surgical drainage (open cystogastrostomy) to LAMS-assisted endoscopic drainage has resulted in a paradigm shift in patient outcomes.

1. Reduced Length of Stay (LOS): Patients undergoing LAMS placement typically require significantly less hospitalization compared to open surgery.
2. Decreased Pain Scores: Minimally invasive access results in lower post-procedural analgesic requirements.
3. Faster Recovery: Patients often return to normal dietary intake within 24-48 hours post-procedure.
4. Lower Morbidity: The avoidance of general anesthesia and large abdominal incisions reduces the risk of wound infections, incisional hernias, and pulmonary complications.

Frequently Asked Questions (FAQ)

1. What is the difference between the 10mm, 15mm, and 20mm AXIOS stents?

The diameter is selected based on the clinical application. 10mm is generally used for gallbladder drainage, while 15mm and 20mm are reserved for necrotic collections that require the passage of debris or endoscopic necrosectomy tools.

2. Can the AXIOS stent be left in place permanently?

No. The AXIOS LAMS is intended for temporary use. It is typically removed after 3–6 weeks once the collection has resolved and the fistula tract has matured.

3. What happens if the stent migrates?

If the stent migrates, it is usually retrieved endoscopically. If it migrates into the collection, it may require surgical retrieval; however, this is rare with proper technique.

4. Is the AXIOS stent MRI compatible?

The Nitinol alloy is considered MR-conditional. Patients should always inform their radiologist of the presence of the stent before undergoing MRI.

5. How do I choose the correct size for my patient?

Consult the clinical guidelines regarding the size of the collection. Always measure the distance between the stomach wall and the target organ via EUS before selecting the stent length.

6. What is the primary cause of stent occlusion?

Occlusion is usually caused by food particles or thick necrotic debris. This is why proper diameter selection is essential.

7. Does the stent require irrigation?

In cases of WON, daily or periodic irrigation of the cavity through the stent may be required to clear necrotic tissue.

8. Is the procedure performed under general anesthesia?

Most EUS-guided LAMS placements are performed under moderate sedation or monitored anesthesia care (MAC), depending on the patient's comorbidities.

9. What are the signs of a failing stent?

Fever, recurrent abdominal pain, or an increase in the size of the fluid collection on follow-up imaging are indicators of stent dysfunction.

10. Can the AXIOS stent be used in patients with ascites?

The presence of significant ascites is a relative contraindication, as it increases the risk of peritoneal leak during the procedure. Careful assessment by an experienced interventionalist is required.

Conclusion

The AXIOS Lumen-Apposing Metal Stent represents a pinnacle of interventional engineering. By combining the biomechanical advantages of Nitinol with the tactical utility of a bi-flanged, electrocautery-enhanced delivery system, it has provided a lifeline to patients with complex pancreatic and biliary conditions. For the clinical specialist, mastery of this device requires an intimate understanding of its technical specifications and a disciplined approach to patient selection and procedural execution. As technology advances, the LAMS continues to prove that in medicine, sometimes the most significant improvements come from the smallest, most precisely engineered devices.